1. P535: UPDATES FROM ITALIAN MULTICENTER REAL-LIFE EXPERIENCE ON CPX-351 THERAPY IN YOUNG PATIENTS (<60 YEARS OLD). (23rd June 2022) Authors: Garibaldi, B.; Franciosa, M.; Pilo, F.; Menotti, D.; Cardinali, V.; Brunetti, L.; Martino, E. A.; Vigna, E.; Tanasi, I.; Duminuco, A.; Maugeri, C.; Parisi, M. S.; Fiumara, P. F.; Mauro, E.; Gentile, M.; Martelli, M. P.; Capelli, D.; Romani, C.; Galimberti, S.; Palumbo, G. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P574: CPX-351 COMBINED WITH HEMATOPOIETIC CELL TRANSPLANTATION WITH REGULATORY AND CONVENTIONAL T CELL IMMUNOTHERAPY FOR HIGH-RISK ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Sciabolacci, S.; Ruggeri, L.; Cardinali, V.; Brunetti, L.; Tricarico, S.; Saldi, S.; Marzuttini, F.; Griselli, M.; Perta, G.; Viglione, V.; Cimino, G.; Osmani, A.; Caridi, M.; Sembenico, R.; Terenzi, A.; Zei, T.; Iacucci Ostini, R.; Martelli, M. F.; Falini, B.; Velardi, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗